Navis Wealth Advisors’s Pfizer PFE Stock Holding History

Navis Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,080	Closed	-$209K	–	92
2022 Q4	$209K	Buy	+4,080	New	+$196K	0.3%	76
2022 Q2	–	Sell	-6,050	Closed	-$313K	–	105
2022 Q1	$313K	Buy	6,050 +1,000	+20%	+$51.9K	0.28%	78
2021 Q4	$298K	Hold	5,050	–	–	0.25%	83
2021 Q3	$217K	Buy	+5,050	New	+$224K	0.15%	117
2021 Q1	–	Sell	-3,050	Closed	-$112K	–	168
2020 Q4	$112K	Buy	+3,050	New	+$112K	0.1%	113

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Navis Wealth Advisors's PFE Position: Q1 2023 in Review

Navis Wealth Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,080 shares — an estimated $209K sold.

Navis Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 5 quarters. The position peaked at $313K in Q1 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Navis Wealth Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Navis Wealth Advisors sold 4,080 Pfizer shares in Q1 2023, an estimated $209K.
Navis Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 5 quarters.
Navis Wealth Advisors's Pfizer position peaked at $313K in Q1 2022.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Navis Wealth Advisors's 13F filing for Q1 2023, filed 12 May 2023.